Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study

This open-label, phase 3b study (ClinicalTrials.gov Identifier: NCT00983073) evaluated the effectiveness, and tolerability of tapentadol for severe, chronic osteoarthritis knee pain that was inadequately managed with World Health Organization (WHO) Step I or II analgesics or co-analgesics, or that w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Steigerwald, Ilona, Müller, Matthias, Kujawa, Jolanta, Balblanc, Jean-Charles, Calvo-Alén, Jaime
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2012
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3392842/
https://ncbi.nlm.nih.gov/pubmed/22792000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S30540
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items